I think this is setting the stage for there to be restrictions on the (much cheaper) compounding of semaglutide.

Here's another article: WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

A quote:

Lilly said in an open letter that it was “deeply concerned” about growing online sales and social media posts involving phony or compounded versions of tirzepatide, the active ingredient behind its drugs Mounjaro and Zepbound.

Note how they're connecting "compounding" with "phony".